September 2018 Funding Opportunities and Announcements
Questions about this "funding flash"? Contact us at cancercenter@gwu.edu. View previous issues here. Interested in subscribing to future updates? Click the button below:
American Cancer Society Postdoctoral Fellowships
Support for researchers who have received a doctoral degree to provide training leading to a career in cancer research.
Deadline: October 15, 2018
Amount and Project Period: $163,500 over 3 years
Eligibility : Researchers who have received a doctoral degree may apply for initial funding to start training for an independent career in cancer research.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: The Society's Scientific Program Directors distribute the applications to the most appropriate Peer Review Committee and then assign each application to at least two committee members for independent and confidential review. Each committee generally has between 12 and 25 members who are leaders in their areas of expertise, plus up to three "stakeholders." A stakeholder is an individual, usually without formal training as a scientist or health professional, who has a strong personal interest in advancing the effort to control and prevent cancer through research and training. This interest could stem from a personal experience with the disease, such as survivorship, a family cancer experience, or being a caregiver.
Rivkin Center for Ovarian Cancer Bridge Funding Awards
Provides interim funding for researchers who have submitted to the NIH or an original proposal to the DoD pertaining to ovarian cancer and who were not funded but received a score close to the funding threshold.
Deadline: October 15, 2018
Amount and Project Period: $30,000 over 6 months
Eligibility : Investigators at all levels are encouraged to apply. Unfunded first submission NIH R01, R21, K08, K23, and K99 proposals (no A1 or A2 proposals) as well as original DoD proposals are eligible for consideration. NIH proposals must have scored in the 20th percentile or lower, and DoD proposals must have scored less than 2.5. Proposals must have received their agency score within the past 9 months. Proposals must require at least six months of additional research work prior to submission.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: Bridge Funding applications will undergo initial review by the Rivkin Center directors to confirm that the applications are complete and to assign appropriate and qualified reviewers. Each application will be assigned a minimum of two reviewers with applicable expertise.
American Association for Cancer Research SU2C Catalyst Research Grants: Genentech-Supported Projects
The SU2C Catalyst is a collaborative initiative intended to leverage all stages of the pharmaceutical, biotechnology, diagnostic, and devices industries (collectively referred to herein as "industry") to bring new treatments to patients as rapidly as possible.
Deadline: October 22, 2018
Amount and Project Period: $3,000,000 over 3 years
Eligibility : The PI, Clinical Lead, and Investigators must have acquired a doctoral or medical degree, and must be independent investigators affiliated with an academic, medical, or research institution. Applications are encouraged from the scientific community, including current and former SU2C grantees and non-SU2C-affiliated scientists. Research must be carried out within the United States. Members of the SU2C Catalyst Executive Committee are not eligible for funding as part of the SU2C Catalyst. Members of SU2C Catalyst Genentech Steering Subcommittee are not eligible for an SU2C Catalyst Research Grant: Genentech-Supported Projects but may apply for other SU2C Catalyst funding opportunities.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: The SU2C Catalyst Genentech Steering Subcommittee will review the proposals for the SU2C Catalyst Research Grants: Genentech Supported Projects. The Subcommittee consists of highly accomplished world class scientists, physician-scientists, and clinicians. The Steering Subcommittee Chair will be drawn from academia. Excluding the Chair, an equal number of Committee members will be drawn from academia and Genentech. All Steering Subcommittee members have relevant scientific expertise, and Genentech members are high-level individuals at Genentech with decision-making authority. The SU2C Catalyst Executive Committee will consider the SU2C Catalyst Genentech Steering Subcommittee recommendations for funding and make the final selection of SU2C Catalyst Genentech grantees.
Melanoma Research Alliance Young Investigator Award
Aims to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders.
Deadline: October 19, 2018 (Applicant Eligibility Checklist)
Amount and Project Period: $225,000 over 3 years
Eligibility : Applicants must be within the first four years of their first independent, full-time academic faculty appointment. Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.
Melanoma Research Alliance Special Opportunity Young Investigator and Established Investigator Awards for Artificial Intelligence Applied to Melanoma
Supports research efforts that use AI to advance melanoma detection, prevention, diagnosis, staging, and/or treatment.
Deadline: October 19, 2018 (Applicant Eligibility Checklist)
Amount and Project Period: $225,000 over 3 years (Young Investigator Applicants), $375,000 over 3 years (Established Investigator Applicants)
Eligibility : Young Investigator Applicants must be within the first four years of their first independent, full-time academic faculty appointment. Established Investigator Applicants must be past the initial four years of their first academic faculty appointment.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.
Melanoma Research Alliance Special Opportunity Young Investigator and Established Investigator Awards in Dermatology
Supports research focused on prevention, diagnosis, and/or treatment of melanoma, and my include research related to dermatology, dermatopathology, and/or dermatologic surgery.
Deadline: October 19, 2018 (Applicant Eligibility Checklist - Young Investigator Applicants only), November 2, 2018 (full proposal)
Amount and Project Period: $225,000 over 3 years (Young Investigator Applicants), $375,000 over 3 years (Established Investigator Applicants)
Eligibility : Young Investigator Applicants must be within the first four years of their first independent, full-time academic faculty appointment. Established Investigator Applicants must be past the initial four years of their first academic faculty appointment. All eligible applicants must hold an appointment in a department or division of dermatology.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.
Melanoma Research Alliance Bristol-Myers Squibb-MRA Young Investigator Awards in Immunotherapy
Supports young investigators conducting projects supported by preliminary data and focused on advancing immunotherapies in melanoma.
Deadline: October 19, 2018 (Applicant Eligibility Checklist)
Amount and Project Period: $225,000 over 3 years
Eligibility : Applicants must be within the first four years of their first independent, full-time academic faculty appointment. Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.
Melanoma Research Alliance Special Opportunity SITC-MRA Young Investigator Award in Immune-Related Adverse Events Associated with Immunotherapy
The purpose of this funding opportunity is to solicit original ideas for identifying the basic mechanism(s) underlying immune-related adverse events associated with approved immunotherapies leading to ways to ameliorate and/or prevent them. In addition to insights into the basic biology of immune-mediated toxicity, applications addressing novel concepts for identifying, diagnosing and treating immune-mediated adverse events are considered highly responsive to this funding opportunity.
Deadline: October 19, 2018 (Applicant Eligibility Checklist)
Amount and Project Period: $225,000 over 3 years
Eligibility : Applicants must be within the first four years of their first independent, full-time academic faculty appointment. Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.
Melanoma Research Alliance Special Opportunity ASTRO-MRA Early Career Investigator Award in Radiation Oncology
Supports research in radiation oncology to improve treatment options for melanoma patients.
Deadline: October 29, 2018 (Applicant Eligibility Checklist)
Amount and Project Period: $200,000 over 3 years. The award also requires a match of $100,000 from the Awardee's institution, either in matching funds or in-kind contribution. This could include facilities and administration costs (F&A), dedicated research time, or other costs covered by the institution. The matching funds can be supplied over the full time frame of the grant.
Eligibility : Applicants must be within the first five years of their initial faculty appointment and a member in good standing of ASTRO.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.
American Society of Hematology Bridge Grant
Granted to ASH members who applied for an NIH R01 grant or equivalent but were denied funding due to budget cutbacks ot help sustain recipients' research and contribute to their retention in hematology investigation.
Deadline: November 1, 2018
Amount and Project Period: $150,000 over 1 year
Eligibility : Applicant must have submitted to the NIH in the past 18 months a hematology-related R01 or R01-equivalent application that was scored but not funded. Applicant must be an ASH member in good standing. Applicant must have the commitment of his/her institution to match $50,000 in funds. At time of award activation, applicant must have available no more than $250,000 annually in other research funding.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: Scientific review committee
Melanoma Research Alliance Pilot Award
Supports senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals.
Deadline: November 2, 2018
Amount and Project Period: $100,000 over 2 years
Eligibility : Applicants must be past the initial four years of their first academic faculty appointment and hold a full-time appointment at the level of Assistant Professor or above.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.
Melanoma Research Alliance Established Investigator Award
Supports senior investigators with an established record of scientific productivity and accomplishment.
Deadline: November 2, 2018
Amount and Project Period: $375,000 over 3 years
Eligibility : Applicants must be past the initial four years of their first academic faculty appointment and hold a full-time appointment at the level of Assistant Professor or above.
Contact: Zack Knowles ( medcfr@email.gwu.edu )
Reviewers: All proposals will undergo rigorous peer review by the MRA Grant Review Committee (GRC), comprised of experts in diverse areas of translational cancer research.